Key Points

  • Apple’s iPhone business generated $54.25 billion in quarterly revenue, nearly half of total company sales, increasing its exposure to rising memory costs.
  • AI data centers are absorbing more global chip capacity, pushing some smartphone-memory prices to more than four times previous levels.
  • Apple’s purchasing power and premium pricing provide protection, but prolonged memory shortages could pressure margins through 2027 and beyond.
hero

Why Is AI Creating a Memory Problem for Apple?

Apple’s iPhone business is facing an increasingly important supply-chain challenge as the explosive expansion of artificial intelligence infrastructure redirects semiconductor capacity toward higher-value memory products. The issue is particularly relevant for Apple because the iPhone remains the company’s largest revenue engine, generating $54.25 billion in its latest reported quarter, or 49.6% of total sales.

The memory market is highly concentrated, with Samsung, SK Hynix and Micron controlling roughly 90% of global supply. As AI data centers demand increasingly large volumes of high-bandwidth memory, manufacturers have a financial incentive to allocate scarce wafer capacity toward those products. That leaves smartphone manufacturers competing for conventional DRAM at a time when available supply is becoming tighter.

The result has already appeared in pricing. Some smartphone-memory components have reportedly increased by more than fourfold, while meaningful supply relief may not arrive until late 2027 or even 2028.

Can Apple Protect Its iPhone Margins?

Apple has advantages that smaller smartphone manufacturers do not. Its enormous purchasing volumes provide negotiating leverage with suppliers, while its premium product portfolio gives management more flexibility to absorb higher component costs or pass some increases on to consumers.

However, purchasing power cannot instantly create additional semiconductor manufacturing capacity. Even Apple’s scale cannot eliminate the underlying supply constraint if memory producers continue prioritizing AI-related demand.

That creates an important margin question. Apple reported a companywide gross margin of 50.1% in its latest quarter, giving the business substantial financial cushioning. But maintaining that profitability becomes more difficult if memory inflation persists for multiple product cycles.

Premium models could provide part of the answer. If consumers remain willing to pay more for upgraded iPhones, Apple may be able to offset higher memory costs through a higher average selling price. The risk is that increasingly expensive upgrades could eventually weaken replacement demand, particularly if consumers perceive fewer meaningful improvements between generations.

Could the AI Boom Become an iPhone Profitability Risk?

The unusual nature of the current semiconductor cycle makes this more than a conventional component-cost problem. AI companies and data-center operators have significantly deeper spending capacity than many traditional electronics customers, allowing them to compete aggressively for scarce memory resources.

For Apple, the challenge is therefore balancing supply security against profitability. Its purchasing scale should help, but prolonged shortages could force the company to pay more for critical components or make strategic decisions about product configurations and inventory.

Apple shares last closed at $319.97 because US markets were closed Monday. At that level, investors appear to be pricing in considerable confidence in the company’s ability to defend its earnings power. The shares also stand above the cited GF Value estimate of $284.79, suggesting expectations are already elevated.

The next several quarters will reveal whether Apple can preserve those expectations. If memory supply improves as new capacity comes online, the current squeeze could prove manageable. If AI demand continues overwhelming conventional semiconductor supply, however, the iPhone’s enormous revenue contribution could become a growing source of earnings pressure rather than an automatic strength.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast?
    • omer bar
    • •
    • 8 Min Read
    • •
    • ago 7 hours

    SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast? SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast?

    Delta Air Lines has lowered its 2026 profit expectations as soaring jet fuel costs weigh on earnings, highlighting the challenge

    • ago 7 hours
    • •
    • 8 Min Read

    Delta Air Lines has lowered its 2026 profit expectations as soaring jet fuel costs weigh on earnings, highlighting the challenge

    SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom?
    • Ronny Mor
    • •
    • 6 Min Read
    • •
    • ago 2 days

    SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom? SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom?

    Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is

    • ago 2 days
    • •
    • 6 Min Read

    Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is

    SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments?
    • Ronny Mor
    • •
    • 7 Min Read
    • •
    • ago 4 days

    SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments? SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments?

    Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the

    • ago 4 days
    • •
    • 7 Min Read

    Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the

    SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business?
    • Lior mor
    • •
    • 8 Min Read
    • •
    • ago 4 days

    SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business? SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business?

    Boeing Expands Its Position in Next-Generation Fighters Boeing has strengthened its position in the U.S. military aircraft market after securing

    • ago 4 days
    • •
    • 8 Min Read

    Boeing Expands Its Position in Next-Generation Fighters Boeing has strengthened its position in the U.S. military aircraft market after securing